5-[6-(4-Methoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline
Title | Journal |
---|---|
Synthesis and structure-activity relationships of a novel and selective bone morphogenetic protein receptor (BMP) inhibitor derived from the pyrazolo[1.5-a]pyrimidine scaffold of dorsomorphin: the discovery of ML347 as an ALK2 versus ALK3 selective MLPCN probe. | Bioorganic & medicinal chemistry letters 20130601 |
Structure-activity relationship study of bone morphogenetic protein (BMP) signaling inhibitors. | Bioorganic & medicinal chemistry letters 20080801 |